Insmed Inc (INSM) is a biotechnology company listed on US.
Latest reported INSM revenue for 2026-06-30 was $731.5M. Net income was -$176.8M. INSM currently screens at market cap $20.42B.
Use this INSM page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the INSM quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the INSM SEC filings page. Lician reads the product cache first so this HTML stays unique to Insmed Inc even when a live quote feed is slow.
Latest cached year on this hub. Full INSM income, balance, and cash tables.